Tele-Dermatology in Clinical Management of Suspected Cutaneous Leishmaniasis in COVID-19 Pandemic
DOI:
https://doi.org/10.3126/njdvl.v18i1.31120Keywords:
COVID-19; Fluconazole; Leishmaniasis, Cutaneous; Pandemics; TelemedicineAbstract
The COVID-19 pandemic has changed the world dynamics in various prospects. It led to the restricted mobility of dermatological patients and helped telemedicine platform to flourish than ever. Though teledermatology has its own pros and cons, it’s being used in treatment of various skin disorders. Cutaneous leishmaniasis is an emerging disease in Nepal whose diagnosis is primarily clinical and histological. We are reporting a case of suspected cutaneous leishmaniasis from far western hilly region of Nepal who was empirically treated with fluconazole with the help of teledermatology platform with outstand outcomes.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright on any research article is transferred in full to Nepal Journal of Dermatology, Venereology & Leprology upon publication. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).